Skip to main content
Top
Literature
1.
go back to reference Liang W, Guan W, Chen R, Wang W, Li J, Xu K et al (2020) Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 21(3):335–337CrossRef Liang W, Guan W, Chen R, Wang W, Li J, Xu K et al (2020) Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 21(3):335–337CrossRef
2.
go back to reference He W, Chen L, Chen L, Yuan G, Fang Y, Chen W et al (2020) COVID-19 in persons with haematological cancers. Leukemia 34:1637–1645CrossRef He W, Chen L, Chen L, Yuan G, Fang Y, Chen W et al (2020) COVID-19 in persons with haematological cancers. Leukemia 34:1637–1645CrossRef
3.
go back to reference Martin-Moro F, Marquet J, Piris M, Michael BM, Saez AJ, Corona M et al (2020) Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies. Br J Haematol 190:e16–e20CrossRef Martin-Moro F, Marquet J, Piris M, Michael BM, Saez AJ, Corona M et al (2020) Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies. Br J Haematol 190:e16–e20CrossRef
4.
go back to reference Mehta V, Goel S, Kabarriti R, Cole D, Goldfinger M, Acuna-Villaorduna A et al (2020) Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov 10:935–941CrossRef Mehta V, Goel S, Kabarriti R, Cole D, Goldfinger M, Acuna-Villaorduna A et al (2020) Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov 10:935–941CrossRef
5.
go back to reference Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR et al (2020) Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. The Lancet 395:1907–1918CrossRef Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR et al (2020) Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. The Lancet 395:1907–1918CrossRef
Metadata
Title
COVID-19 in Adult Patients with Hematological Disease: Analysis of Clinical Characteristics and Outcomes
Authors
R. Lattenist
H. Yildiz
J. De Greef
S. Bailly
J.C. Yombi
Publication date
01-01-2021
Publisher
Springer India
Keyword
COVID-19
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 1/2021
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-020-01318-4

Other articles of this Issue 1/2021

Indian Journal of Hematology and Blood Transfusion 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine